Vanda Pharmaceuticals Inc. Share Price & Technical Analysis
VNDA · $6.19 (-0.32%)
Healthcare / Biotechnology
$6.19
-0.32%
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nightti…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-13% return in May, -1% avg return in past 3 year May month.
-29% return in 2026, 16% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -14% | 17% | -21% | 1% | -13% | – | – | – | – | – | – | – | -29% |
| 25 | -8% | 12% | -4% | -2% | -4% | 9% | -9% | 12% | 6% | -14% | 23% | 66% | 86% |
| 24 | -14% | 22% | -9% | 14% | 6% | 10% | 2% | -10% | -11% | 0% | 11% | -8% | 12% |
| 23 | 4% | -17% | 6% | -10% | -5% | 10% | -12% | -10% | -17% | 2% | -16% | 14% | -52% |
| 22 | -4% | -23% | -2% | -13% | -1% | 9% | -1% | -1% | -6% | 4% | 4% | -32% | -66% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion. It also develops Fanapt (iloperidone), a long acting injectable (LAI) formulation for the treatment of schizophrenia and hypertension; BysantiTM (milsaperidone), for the acute treatment of manic or mixed episodes associated with bipolar I disorder, and for the treatment of schizophrenia and major depressive disorder; HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, pediatric insomnia, delayed sleep phase disorder, and pediatric Non-24; PONVORY (ponesimod) to treat psoriasis and ulcerative colitis; and NEREUSTM (tradipitant) for prevention of vomiting induced by GLP-1 receptor agonists, as well as treatment of gastroparesis and atopic dermatitis. In addition, the company's products include Imsidolimab, an IL-36R antagonist to treat generalized pustular psoriasis; VTR-297, for the treatment of hematologic malignancies and onychomycosis, and several oncology indications; and VQW-765, small molecule alpha-7 nicotinic acetylcholine receptor partial agonist for the treatment of social/performance anxiety and psychiatric disorders. Further, it develops cystic fibrosis transmembrane conductance regulator activators and inhibitors; and antisense oligonucleotide molecules. The company was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$375.85M
P/E ratio
—
52W high
$9.94
52W low
$4.14
Volume
8,84,197
Beta
0.65
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Vanda Pharmaceuticals Inc. share price today?
- Vanda Pharmaceuticals Inc. (VNDA) last traded around $6.19 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does VNDA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for VNDA. Download the app for real-time alerts.
- How can I analyze Vanda Pharmaceuticals Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.